CHAMPIONS ONCOLOGY UK LIMITEDActive

Company number 06861239Private limited companyIncorporated 2009

Key figures

−570,513 USD+2.0%
Net assets 2024/25
-800 k-600 k-400 k-200 k02019/202023/242024/25

Amounts are in USD (the currency of the accounts).

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k150 k2019/202023/242024/25
Filed accounts2019/20–2024/25
2019/202023/242024/25
Turnover928,5272,078,8921,783,479
Profit for the year000
Cash at bank and in hand16,58562,46666,122
Total assets20,84077,256101,036
Total liabilities———
Net assets / total equity-607,625-582,145-570,513
Average number of employees6120

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company in the year under review was that of a holding company for a branch.

As described in the company's latest filed accounts.

Summary: CHAMPIONS ONCOLOGY UK LIMITED

Company

CHAMPIONS ONCOLOGY UK LIMITED is a private limited company registered with Companies House under company number 06861239. It was incorporated on 27 Mar 2009. Its status is active. The registered office is in London (SW1H). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files medium company accounts. Turnover was 1,783,479 USD. Profit for the year was 0 USD. Net assets were −570,513 USD, up 2% on the previous year. Cash at bank and in hand was 66,122 USD. The company had an average of 0 employees. Figures are available for 3 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 10 Apr 2027.